Pulmonology

Highmark Health, Allegheny Health Network Unveil North Fayette Health + Wellness Pavilion

Retrieved on: 
Wednesday, March 1, 2023
Sentinel, Neurosurgery, Infertility, Cardiology, Endocrinology, Doctor of Philosophy, Allegheny Health Network, IVF, Artificial insemination, Elective surgery, X-ray, Mammography, Anatomy, Reproductive medicine, Drive, Rheumatology, Life, New Home, Pavilion, Express, Gastroenterology, Patient, Google Images, Neurology, AHN, DEXA, Obstetrics, Site, Pulmonology, Bariatrics, Mental health, Woman, NORTH, Health, Hospital, Nursing, Medical imaging, Podiatry, MD

NORTH FAYETTE, Pa., March 1, 2023 /PRNewswire-PRWeb/ -- Representatives of Highmark Health and Allegheny Health Network (AHN) today joined community leaders for a ceremonial ribbon-cutting to celebrate the launch of AHN's North Fayette Health + Wellness Pavilion – a state-of-the-art facility offering an array of primary and specialty outpatient services anchored by the network's Center for Reproductive Medicine.

Key Points: 
  • "Today marks the latest milestone for AHN and Highmark Health in our ongoing journey to transform health care for patients and their families in the communities where they live and work," said Bruce Meyer, MD, Executive Vice President and Western PA Market President, Highmark Health.
  • AHN North Fayette will house one of the area's first 3T MRI scanners – a leading-edge technology that produces exceptionally detailed images of the anatomy.
  • AHN partnered with Orangestar Property Advisors and Sentinel Construction to develop the North Fayette Health + Wellness Pavilion.
  • North Fayette will become AHN's sixth Health + Wellness Pavilion, joining others serving the communities of Wexford, Bethel Park, Peters Township and Erie's east and west sides.

Carestream Explores Potential of X-ray Imaging for Earlier Detection and Treatment of Idiopathic Pulmonary Fibrosis

Retrieved on: 
Wednesday, March 1, 2023
Cardiology, Biotechnology, Other Health, Health, General Health, Radiology, Biometrics, Medical Devices, Research, Hospitals, Science, Vital capacity, Pulmonology, CTS, Pathology, Diagnosis, Project, Artificial intelligence, Biomarker, Algorithm, Standard of care, Patient, CT, APF, Cough, AI, Pulmonary fibrosis, Innovation, American Lung Association, Idiopathic pulmonary fibrosis, IPF, Open source, Blood, FVC, ALA, X-ray, Intelligence Advanced Research Projects Activity, EU, OPUS, Medical imaging, Carestream Health

Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging Consortium (OSIC) that could lead to radiographs providing an early window into manifestations of idiopathic pulmonary fibrosis (IPF) that are currently undetected, thus leading to earlier diagnosis and treatment.

Key Points: 
  • Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging Consortium (OSIC) that could lead to radiographs providing an early window into manifestations of idiopathic pulmonary fibrosis (IPF) that are currently undetected, thus leading to earlier diagnosis and treatment.
  • “If this pilot uncovers markers that are currently undetected in X-rays, it could lead to earlier detection and treatment of patients with IPF.
  • Project OPUS is a collaborative effort between OSIC, Carestream, patientMpower, the American Lung Association (ALA) , European Pulmonary Fibrosis Federation (EU-IPFF) and Action for Pulmonary Fibrosis (APF) .
  • “Project OPUS is just one area where Carestream is exploring the potential of X-ray imaging to play an expanded role in diagnosis and care management of various pathologies,” said Dr. Bogoni.

Aluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their Doctors

Retrieved on: 
Tuesday, January 31, 2023
Software, Managed Care, General Health, Health, Medical Devices, Health Technology, Technology, Apps, Applications, Ignition, Karma, Matrix, Insurance, Heel, ML, Matrix Partners, General partnership, Remote patient monitoring, Gold, Cystic fibrosis, Meena Jutla, Allergist, Pulmonology, Patient, Series, Credit Karma, Silicon, Venture round, COPD, Immunology, Marketing, Growth, UC, American College, Octane, Zendesk, MD, Pharmaceutical industry, Aluna, Asthma

Aluna , the award-winning lung health management platform, today announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.

Key Points: 
  • Aluna , the award-winning lung health management platform, today announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.
  • Aluna’s AI-enabled respiratory management platform allows patients to transmit data to their doctor by blowing into their innovative spirometer daily.
  • Their proprietary ML algorithms help medical teams identify respiratory problems and take corrective action to keep their health under control.
  • Led by previous investor Matrix Partners, the Series B round brings Aluna’s total funding since inception to $27 million.

Mark E. Kutner, MD, is being recognized by Continental Who's Who

Retrieved on: 
Monday, February 13, 2023
Nose, Pharmacy, Pulmonology, Hospital, Northwestern Memorial Hospital, Internal medicine, Continental, Patient, American Board of Internal Medicine, Respiratory system, Johns Hopkins Hospital, Family, Vital, American Board of Commissioners for Foreign Missions, MD, Pharynx, ABIM, Nursing, Medicine

MIAMI, Feb. 13, 2023 /PRNewswire/ -- Mark E. Kutner, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an Internist and Pulmonologist and for his contributions to the healthcare field.

Key Points: 
  • MIAMI, Feb. 13, 2023 /PRNewswire/ -- Mark E. Kutner, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional as an Internist and Pulmonologist and for his contributions to the healthcare field.
  • Dr. Kutner earned a medical degree from the SUNY Stony Brook School of Medicine in 1983.
  • The doctor is board-certified in both pulmonary disease and internal medicine by the American Board of Internal Medicine (ABIM).
  • Dr. Kutner has been in practice since 1988 and has been with PrimeHealth Physicians since its inception about nine years ago.

Aluna and ModuleMD Partner to Bring 24/7 Remote Patient Monitoring to Practices and Respiratory Patients

Retrieved on: 
Monday, February 6, 2023
RPM, Allergy, Workflow, Patient, Cystic fibrosis, Allergist, Pulmonology, RCM, Asthma, EHR, Partnership, SAN, ONC, Practice management, Nursing, Aluna

SAN FRANCISCO, Feb. 6, 2023 /PRNewswire/ -- Today Aluna, an award-winning connected care platform and at-home spirometer, announced a partnership with ModuleMD, ONC Certified EHR, leading practice management and EHR SaaS solution for allergists and pulmonologists, to improve patient and provider access to the latest technology in lung health. Patients with asthma and cystic fibrosis will now be able to seamlessly share their daily fluctuations in lung health with their doctor, enabling better outcomes and fewer attacks through earlier and more frequent interventions.

Key Points: 
  • This collaboration will facilitate seamless sharing between providers, payers, and patients throughout the Aluna RPM care management platform with all the details integrated into the providers' workflow in ModuleMD.
  • "Close monitoring of asthma and other lung conditions is correlated with better patient outcomes," said Charvi Shetty, Founder and CEO of Aluna.
  • Through this integration with Aluna, medical practices now have a seamless RPM experience to deliver comprehensive care to patients."
  • Learn more about how practices can benefit from the Aluna and ModuleMD technology and service offerings.

What Are The Major Trend-Based Strategies That Players In The USA Pulmonologists Market Are Focusing On To Improve Treatment?

Retrieved on: 
Tuesday, January 24, 2023
Software, Diagnosis, Education, Endoscopy, Telehealth, Pulmonology, Respiratory system, Prevalence, Robotics, Patient, Tissue, Medical device, Hospital, Mercy Health

LONDON, Jan. 24, 2023 /PRNewswire/ -- As per The Business Research Company's pulmonologist market report, the increase in prevalence of lung disorders and the growing size of the geriatric population has compelled major players in the pulmonologist market to adopt advanced technologies to aid better treatment. Robotic Bronchoscopy is one such advanced diagnostic technology that pulmonologists are increasingly relying on for early and accurate detection of abnormal tissues in the lungs.

Key Points: 
  • Robotic Bronchoscopy is one such advanced diagnostic technology that pulmonologists are increasingly relying on for early and accurate detection of abnormal tissues in the lungs.
  • The USA pulmonologist market size is expected to grow from $2.1 billion in 2023 to $2.6 billion at a compound annual growth rate (CAGR) of 7.6%.
  • The pulmonologist market is then expected to grow to $3.8 billion in 2031 at a compound annual growth rate (CAGR) of 7.5%.
  • Because of the pulmonologist market's consistent growth potential, several market players are implementing various technological advancements as well as offering home healthcare services to remain competitive in the pulmonologist market.

What Are The Major Trend-Based Strategies That Players In The USA Pulmonologists Market Are Focusing On To Improve Treatment?

Retrieved on: 
Tuesday, January 24, 2023
Software, Diagnosis, Education, Endoscopy, Telehealth, Pulmonology, Respiratory system, Prevalence, Robotics, Patient, Tissue, Medical device, Hospital, Mercy Health

LONDON, Jan. 24, 2023 /PRNewswire/ -- As per The Business Research Company's pulmonologist market report, the increase in prevalence of lung disorders and the growing size of the geriatric population has compelled major players in the pulmonologist market to adopt advanced technologies to aid better treatment. Robotic Bronchoscopy is one such advanced diagnostic technology that pulmonologists are increasingly relying on for early and accurate detection of abnormal tissues in the lungs.

Key Points: 
  • Robotic Bronchoscopy is one such advanced diagnostic technology that pulmonologists are increasingly relying on for early and accurate detection of abnormal tissues in the lungs.
  • The USA pulmonologist market size is expected to grow from $2.1 billion in 2023 to $2.6 billion at a compound annual growth rate (CAGR) of 7.6%.
  • The pulmonologist market is then expected to grow to $3.8 billion in 2031 at a compound annual growth rate (CAGR) of 7.5%.
  • Because of the pulmonologist market's consistent growth potential, several market players are implementing various technological advancements as well as offering home healthcare services to remain competitive in the pulmonologist market.

4D Molecular Therapeutics Announces Updates on Clinical Pipeline and Additional Preclinical Programs

Retrieved on: 
Monday, January 9, 2023
IND, Disease, Partner (business rank), Echocardiography, PRISM, Clinical trial, Heart, Dialysis, A101, MD, GA, M.A, Degenerative disease, CF, Initiation, University of Nevada, Reno, Biopsy, Interim, NIH, QOL, University, IHC, Cystic fibrosis, Kidney, AMD, Toxic leukoencephalopathy, Intravitreal administration, RNA, Drug discovery, MRI, Choroideremia, Real-time, GMP, Stanford University School of Medicine, Development, Ahus, Fabry disease, Geographic atrophy, FDA, Retinitis pigmentosa, KCCQ, Addition, Atypical hemolytic uremic syndrome, Fabry, Principal, Ophthalmology, VG, Pulmonology, Enzyme replacement therapy, CFTR, DME, Clinical research, Safety, Diabetic retinopathy, ISH, Modulation, Pharmaceutical industry, Vaccine, 3D printing, Medical imaging, Patient

The doses to be evaluated in DME are expected to be similar to those used in the 4D-150 wet AMD clinical trial.

Key Points: 
  • The doses to be evaluated in DME are expected to be similar to those used in the 4D-150 wet AMD clinical trial.
  • It is estimated that there are over one million individuals with GA in the United States according to published data.
  • In addition, I’m excited by the potential of 4D-175, the new preclinical product candidate utilizing the same R100 vector.
  • Cardiac clinical endpoint data (MRI, echocardiography, cardiopulmonary exercise testing [CPET] and QOL assessment) from evaluations at baseline and 12 months after treatment were assessed.

Global Cord Blood and Tissue Banking Industry Report 2022: More than 70% of the Global Cord Blood Market is controlled by the World's 12 Largest Cord Blood Banking Operators - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Biotechnology, Baby, Maternity, Health, Consumer, Tooth fairy, Hypoxia (medical), Cerebral palsy, Infertility, Stemcell Technologies, Microsoft, Pulmonology, MNC, Autism, Bone marrow, Research, TNC, Stroke, ClinicalTrials.gov, Acquisition, Transplant, Regenerative medicine, Retail, Medical imaging, Pharmaceutical industry, Vaccine, Trapping, Firewood, Hospital, Dentistry

Today, more than 70% of the global cord blood market is controlled by the world's 12 largest cord blood banking operators.

Key Points: 
  • Today, more than 70% of the global cord blood market is controlled by the world's 12 largest cord blood banking operators.
  • Substantial cord blood industry consolidation has happened in recent years and investor appetite for cord blood banks has never been stronger.
  • Specifically, cord blood, cord tissue, placental tissue, and dental pulp have demonstrated intriguing therapeutic promise, causing storage services for these biomaterials to proliferate.
  • What are the prices for processing and storage of cord blood in private cord blood banks?

PERSOWN Inc. to launch SMASH-H, a near-real-time Sepsis Monitoring and Alerting System for Hospitals and Home powered by SAS advanced analytics

Retrieved on: 
Tuesday, January 10, 2023
SAS, Pulmonology, MD, Sepsis, Death, Hospital, Risk, Patient, Mortality, AI, Machine learning, Global Medical Device Nomenclature, Informatics, National Association Medical Staff Services, Incidence, Intelligence, Pharmaceutical industry, Medicine

ATLANTA, Jan. 10, 2023 /PRNewswire/ -- Medical information technology and diagnostics company PERSOWN, Inc. is addressing the global burden of sepsis with the launch of the open platform SMASH-H (Sepsis Monitoring and Alerting System for Hospitals and Homes), powered by healthcare analytics from SAS .

Key Points: 
  • ATLANTA, Jan. 10, 2023 /PRNewswire/ -- Medical information technology and diagnostics company PERSOWN, Inc. is addressing the global burden of sepsis with the launch of the open platform SMASH-H (Sepsis Monitoring and Alerting System for Hospitals and Homes), powered by healthcare analytics from SAS .
  • SMASH-H will provide hospitals access to a common set of predictive models designed to enhance existing IT platforms, monitoring tools and diagnostic products.
  • Sepsis has one of the highest mortality rates of any hospital condition, estimated at 15% to 30%.
  • PERSOWN seeks collaborative hospitals from around the world to launch the platform for clinical researchers and treatment protocol analytics.